Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:03:47 EST Tue 02 Dec 2025
Enter Symbol
or Name
USA
CA



Q:BLRX - BIOLINE RX LTD SPON ADR EACH REP 600 ORD SHS (P/S) - https://www.biolinerx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BLRX - Q0.13.19·3.303.43.3857-0.0443-1.319.3571153.38  3.3857  3.1414.696  2.300114:42:49Nov 2415 min RT 2¢

Recent Trades - Last 10 of 115
Time ETExPriceChangeVolume
14:42:49Q3.30-0.045
14:35:12Q3.3857-0.0443127
14:35:12Q3.30-0.0431
14:34:24Q3.23-0.1115
14:26:49Q3.2969-0.043132
14:16:41Q3.23-0.20168
14:16:41Q3.23-0.20100
14:16:41Q3.23-0.20100
14:16:41Q3.23-0.1168
14:16:41Q3.21-0.1331

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-11-24 07:00U:BLRXNews ReleaseBioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-18 07:00U:BLRXNews ReleaseBioLineRx to Report Third Quarter 2025 Results on November 24, 2025
2025-11-17 07:00U:BLRXNews ReleaseBioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
2025-09-29 07:00U:BLRXNews ReleaseBioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers
2025-08-14 07:00U:BLRXNews ReleaseBioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update
2025-08-07 07:00U:BLRXNews ReleaseBioLineRx to Report Second Quarter 2025 Results on August 14, 2025
2025-05-27 07:00U:BLRXNews ReleaseBioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update
2025-05-20 07:00U:BLRXNews ReleaseBioLineRx to Report First Quarter 2025 Results on May 27, 2025
2025-03-31 07:00U:BLRXNews ReleaseBioLineRx Reports 2024 Financial Results and Provides Corporate Update
2025-01-21 07:00U:BLRXNews ReleaseBioLineRx Issues Letter to Shareholders
2025-01-17 07:00U:BLRXNews ReleaseBioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares
2025-01-06 08:55U:BLRXNews ReleaseBioLineRx Announces $10 Million Registered Direct Offering